 SAN DIEGO, Feb. 22, 2021 GLOBE NEWSWIRE -- Fate Therapeutics, Inc. the Company or Fate Therapeutics NASDAQ: FATE, a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer, announced today that the Company will present at the upcoming 10th Annual SVB Leerink Healthcare Conference on Thursday, February 25, 2021, at 5:00 p.m. EST. 